StockNews.AI

Nanox Expands in Europe with New Nanox.ARC Distribution Engagement in Serbia, Montenegro, and Bosnia and Herzegovina

StockNews.AI • 5 hours

MDGLEXASCOGN
High Materiality8/10

Information

Collaboration with Adriamed drives commercial expansion and strengthens Nanox's regional leadership ...

Original source

AI Summary

Nanox partners with Adriamed for European market expansion. Nanox.ARC technology enhances diagnostic capabilities, reducing costs. Exclusive regional partnership targets Serbia, Montenegro, and Bosnia. Nanox aims to improve patient care through strategic collaborations. Adriamed's network supports broader access to medical imaging.

Sentiment Rationale

This collaboration expands Nanox's footprint in a promising market, potentially increasing revenue. Historical partnerships in similar markets have led to significant sales growth.

Trading Thesis

Strategic partnerships like this often take time to yield substantial results in revenue. Future installments and market growth will likely drive continued interest and stock appreciation.

Market-Moving

  • Nanox partners with Adriamed for European market expansion.
  • Nanox.ARC technology enhances diagnostic capabilities, reducing costs.
  • Exclusive regional partnership targets Serbia, Montenegro, and Bosnia.

Key Facts

  • Nanox partners with Adriamed for European market expansion.
  • Nanox.ARC technology enhances diagnostic capabilities, reducing costs.
  • Exclusive regional partnership targets Serbia, Montenegro, and Bosnia.
  • Nanox aims to improve patient care through strategic collaborations.
  • Adriamed's network supports broader access to medical imaging.

Companies Mentioned

  • MDGL (MDGL)
  • EXAS (EXAS)
  • COGN (COGN)

Corporate Developments

This partnership represents a significant move for Nanox in strategic growth markets, enhancing its competitive position. Such developments are critical for establishing market presence and can lead to increased investor confidence.

Nanox Expands in Europe Through New Distribution Collaboration

On January 14, 2026, Nanox Imaging Ltd. (NASDAQ: NNOX) announced a significant new collaboration with Adriamed d.o.o. Beograd, enhancing its presence in the Southeast European medical imaging market. This partnership aims to distribute the innovative Nanox.ARC, a multi-source digital tomosynthesis system, across Serbia, Montenegro, and Bosnia and Herzegovina, further solidifying Nanox's regional leadership in advanced medical imaging technology.

Strengthening Regional Leadership

This collaboration with Adriamed, a well-regarded medical device distributor in the region, will facilitate the implementation of the Nanox.ARC system, which utilizes cutting-edge 3D imaging technology. This technology is designed to deliver enhanced diagnostic capabilities while being more cost-effective than traditional imaging systems, addressing the need for improved healthcare solutions in underserved areas.

The Nanox.ARC has received CE Mark certification, allowing its commercialization throughout Europe in accordance with local regulatory requirements. Adriamed will serve as the exclusive distributor for the Nanox.ARC system in the region, managing marketing, distribution, installation, and support services.

Strategic Expansion Across Europe

Erez Meltzer, CEO and Acting Chairman of Nanox, emphasized the importance of this strategic engagement, stating, “We are building momentum in Europe through this collaboration with Adriamed, whose expertise and regional reach will support our commercial expansion in the Western Balkans.” Meltzer highlighted Nanox's ongoing strategy to enhance accessibility to cost-effective imaging solutions through partnerships in Europe.

Following recent collaborations in Greece, Romania, Czech Republic, and France, this initiative is a critical step in addressing the rising demand for advanced healthcare solutions across multiple European markets.

Enhancing Access to Quality Medical Imaging

Nebojša Čobanov, MD, Chief Financial & Business Development Officer of Adriamed, expressed enthusiasm for the partnership, stating, “Nanox.ARC is a groundbreaking technology with the potential to help close the gap in access and to make high-quality imaging more affordable and widely available.” He added that the collaboration aims to support broader access to medical imaging throughout the Western Balkans, leveraging Adriamed's established market presence.

About Nanox and Adriamed

Nanox, branded under the stock symbol NNOX, focuses on driving innovations in preventive healthcare through an integrated medical imaging and healthcare services platform. Their approach combines affordable imaging hardware, AI solutions, and cloud-based services to enhance diagnostic capabilities and improve patient outcomes.

Adriamed, located in Belgrade and part of the Adriamed Group, is committed to advancing healthcare with innovative solutions, emphasizing the importance of quality and effective distribution in the medical device sector.

Forward-looking Statements

This announcement includes forward-looking statements that involve risks and uncertainties. These statements may include expectations regarding the performance and commercial success of the Nanox.ARC and the company’s future collaborations. 

Factors that could affect actual results include regulatory approvals, market acceptance of the Nanox system, competition, and broader economic conditions.

Related News